APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Preventive

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Asthma Preventive Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchAsthma Preventive Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Preventive Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Asthma Preventive Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Preventive Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Preventive Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Asthma Preventive market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Asthma Preventive include Novartis, Merck, Roche, Pfizer, GSK, Amgen, Astrazeneca, Sumitomo Dainippon Pharma and Chiesi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Asthma Preventive market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Asthma Preventive and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Asthma Preventive sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Asthma Preventive market size, projected growth trends, production technologies, key applications, and end-use industries.

Asthma Preventive Segment by Company

Novartis

Merck

Roche

Pfizer

GSK

Amgen

Astrazeneca

Sumitomo Dainippon Pharma

Chiesi

Boehringer Ingelheim

Biotest AG

Abbot

Asthma Preventive Segment by Type

Sodium Cromolyn

Prednisolone

Asthma Preventive Segment by Application

Children

Adult

Asthma Preventive Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Preventive market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Preventive and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Preventive.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Asthma Preventive market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Asthma Preventive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Asthma Preventive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Asthma Preventive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Asthma Preventive Industry Trends Table 2. Asthma Preventive Industry Drivers Table 3. Asthma Preventive Industry Opportunities and Challenges Table 4. Asthma Preventive Industry Restraints Table 5. Global Asthma Preventive Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Asthma Preventive Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Asthma Preventive Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Asthma Preventive Sales Market Share by Manufacturers Table 9. Global Asthma Preventive Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Asthma Preventive Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Asthma Preventive Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Asthma Preventive Manufacturers, Product Type & Application Table 13. Global Asthma Preventive Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Asthma Preventive by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Sodium Cromolyn Table 17. Major Manufacturers of Prednisolone Table 18. Global Asthma Preventive Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Asthma Preventive Sales by Type (2021-2026) & (k units) Table 20. Global Asthma Preventive Sales by Type (2027-2032) & (k units) Table 21. Global Asthma Preventive Sales Market Share by Type (2021-2026) Table 22. Global Asthma Preventive Sales Market Share by Type (2027-2032) Table 23. Global Asthma Preventive Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Asthma Preventive Revenue by Type (2021-2026) & (k units) Table 25. Global Asthma Preventive Revenue by Type (2027-2032) & (k units) Table 26. Global Asthma Preventive Revenue Market Share by Type (2021-2026) Table 27. Global Asthma Preventive Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Children Table 29. Major Manufacturers of Adult Table 30. Global Asthma Preventive Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Asthma Preventive Sales by Application (2021-2026) & (k units) Table 32. Global Asthma Preventive Sales by Application (2027-2032) & (k units) Table 33. Global Asthma Preventive Sales Market Share by Application (2021-2026) Table 34. Global Asthma Preventive Sales Market Share by Application (2027-2032) Table 35. Global Asthma Preventive Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Asthma Preventive Revenue by Application (2021-2026) & (k units) Table 37. Global Asthma Preventive Revenue by Application (2027-2032) & (k units) Table 38. Global Asthma Preventive Revenue Market Share by Application (2021-2026) Table 39. Global Asthma Preventive Revenue Market Share by Application (2027-2032) Table 40. Global Asthma Preventive Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Asthma Preventive Sales by Region (2021-2026) & (k units) Table 42. Global Asthma Preventive Sales Market Share by Region (2021-2026) Table 43. Global Asthma Preventive Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Asthma Preventive Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Asthma Preventive Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Asthma Preventive Sales by Country (2021-2026) & (k units) Table 47. North America Asthma Preventive Sales by Country (2027-2032) & (k units) Table 48. Europe Asthma Preventive Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Asthma Preventive Sales by Country (2021-2026) & (k units) Table 50. Europe Asthma Preventive Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Asthma Preventive Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Asthma Preventive Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Asthma Preventive Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Asthma Preventive Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Asthma Preventive Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Asthma Preventive Sales by Country (2027-2032) & (k units) Table 57. Global Asthma Preventive Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Asthma Preventive Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Asthma Preventive Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Asthma Preventive Revenue Market Share by Region (2021-2026) Table 61. Global Asthma Preventive Revenue Market Share by Region (2027-2032) Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Novartis Asthma Preventive Product Portfolio Table 66. Novartis Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Merck Asthma Preventive Product Portfolio Table 71. Merck Recent Development Table 72. Roche Company Information Table 73. Roche Business Overview Table 74. Roche Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Roche Asthma Preventive Product Portfolio Table 76. Roche Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Pfizer Asthma Preventive Product Portfolio Table 81. Pfizer Recent Development Table 82. GSK Company Information Table 83. GSK Business Overview Table 84. GSK Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. GSK Asthma Preventive Product Portfolio Table 86. GSK Recent Development Table 87. Amgen Company Information Table 88. Amgen Business Overview Table 89. Amgen Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Amgen Asthma Preventive Product Portfolio Table 91. Amgen Recent Development Table 92. Astrazeneca Company Information Table 93. Astrazeneca Business Overview Table 94. Astrazeneca Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Astrazeneca Asthma Preventive Product Portfolio Table 96. Astrazeneca Recent Development Table 97. Sumitomo Dainippon Pharma Company Information Table 98. Sumitomo Dainippon Pharma Business Overview Table 99. Sumitomo Dainippon Pharma Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio Table 101. Sumitomo Dainippon Pharma Recent Development Table 102. Chiesi Company Information Table 103. Chiesi Business Overview Table 104. Chiesi Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Chiesi Asthma Preventive Product Portfolio Table 106. Chiesi Recent Development Table 107. Boehringer Ingelheim Company Information Table 108. Boehringer Ingelheim Business Overview Table 109. Boehringer Ingelheim Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Boehringer Ingelheim Asthma Preventive Product Portfolio Table 111. Boehringer Ingelheim Recent Development Table 112. Biotest AG Company Information Table 113. Biotest AG Business Overview Table 114. Biotest AG Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Biotest AG Asthma Preventive Product Portfolio Table 116. Biotest AG Recent Development Table 117. Abbot Company Information Table 118. Abbot Business Overview Table 119. Abbot Asthma Preventive Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Abbot Asthma Preventive Product Portfolio Table 121. Abbot Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Asthma Preventive Distributors List Table 125. Asthma Preventive Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Asthma Preventive Product Image Figure 2. Global Asthma Preventive Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Preventive Market Size (2021-2032) & (US$ Million) Figure 4. Global Asthma Preventive Sales (2021-2032) & (k units) Figure 5. Global Asthma Preventive Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Asthma Preventive Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Sodium Cromolyn Image Figure 9. Prednisolone Image Figure 10. Global Asthma Preventive Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Asthma Preventive Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Asthma Preventive Sales Market Share by Type (2021-2032) Figure 13. Global Asthma Preventive Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Asthma Preventive Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Asthma Preventive Revenue Market Share by Type (2021-2032) Figure 16. Children Image Figure 17. Adult Image Figure 18. Global Asthma Preventive Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Asthma Preventive Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Asthma Preventive Sales Market Share by Application (2021-2032) Figure 21. Global Asthma Preventive Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Asthma Preventive Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Asthma Preventive Revenue Market Share by Application (2021-2032) Figure 24. North America Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Asthma Preventive Sales Market Share by Country (2021-2032) Figure 26. U.S. Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Asthma Preventive Sales Market Share by Country (2021-2032) Figure 31. Germany Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Asthma Preventive Sales Market Share by Country (2021-2032) Figure 38. China Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Asthma Preventive Sales Market Share by Country (2021-2032) Figure 46. Brazil Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Asthma Preventive Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Asthma Preventive Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Asthma Preventive Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Asthma Preventive Revenue (2021-2032) & (US$ Million) Figure 57. North America Asthma Preventive Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Asthma Preventive Revenue (2021-2032) & (US$ Million) Figure 59. Europe Asthma Preventive Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Asthma Preventive Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Asthma Preventive Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Asthma Preventive Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Asthma Preventive Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asthma Preventive Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Asthma Preventive Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Sodium Cromolyn
  • Prednisolone
Applications
  • Children
  • Adult
Companies covered
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GSK
  • Amgen
  • Astrazeneca
  • Sumitomo Dainippon Pharma
  • Chiesi
  • Boehringer Ingelheim
  • Biotest AG
  • Abbot

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Asthma Preventive Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Asthma Preventive Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Asthma Preventive Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Asthma Preventive Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Asthma Preventive Market Dynamics
  1. 2.1 Asthma Preventive Industry Trends
  2. 2.2 Asthma Preventive Industry Drivers
  3. 2.3 Asthma Preventive Industry Opportunities and Challenges
  4. 2.4 Asthma Preventive Industry Restraints
3 Asthma Preventive Market by Manufacturers
  1. 3.1 Global Asthma Preventive Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Asthma Preventive Sales by Manufacturers (2021-2026)
  3. 3.3 Global Asthma Preventive Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Asthma Preventive Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Asthma Preventive Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Asthma Preventive Manufacturers, Product Type & Application
  7. 3.7 Global Asthma Preventive Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Asthma Preventive Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Asthma Preventive Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Asthma Preventive Tier 1, Tier 2, and Tier 3
4 Asthma Preventive Market by Type
  1. 4.1 Asthma Preventive Type Introduction
  2. 4.1.1 Sodium Cromolyn
  3. 4.1.2 Prednisolone
  4. 4.2 Global Asthma Preventive Sales by Type
  5. 4.2.1 Global Asthma Preventive Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Asthma Preventive Sales by Type (2021-2032)
  7. 4.2.3 Global Asthma Preventive Sales Market Share by Type (2021-2032)
  8. 4.3 Global Asthma Preventive Revenue by Type
  9. 4.3.1 Global Asthma Preventive Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Asthma Preventive Revenue by Type (2021-2032)
  11. 4.3.3 Global Asthma Preventive Revenue Market Share by Type (2021-2032)
5 Asthma Preventive Market by Application
  1. 5.1 Asthma Preventive Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Asthma Preventive Sales by Application
  5. 5.2.1 Global Asthma Preventive Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Asthma Preventive Sales by Application (2021-2032)
  7. 5.2.3 Global Asthma Preventive Sales Market Share by Application (2021-2032)
  8. 5.3 Global Asthma Preventive Revenue by Application
  9. 5.3.1 Global Asthma Preventive Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Asthma Preventive Revenue by Application (2021-2032)
  11. 5.3.3 Global Asthma Preventive Revenue Market Share by Application (2021-2032)
6 Global Asthma Preventive Sales by Region
  1. 6.1 Global Asthma Preventive Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Asthma Preventive Sales by Region (2021-2032)
  3. 6.2.1 Global Asthma Preventive Sales by Region (2021-2026)
  4. 6.2.2 Global Asthma Preventive Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Asthma Preventive Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Asthma Preventive Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Asthma Preventive Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Asthma Preventive Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Asthma Preventive Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Asthma Preventive Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Asthma Preventive Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Asthma Preventive Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Asthma Preventive Revenue by Region
  1. 7.1 Global Asthma Preventive Revenue by Region
  2. 7.1.1 Global Asthma Preventive Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Asthma Preventive Revenue by Region (2021-2026)
  4. 7.1.3 Global Asthma Preventive Revenue by Region (2027-2032)
  5. 7.1.4 Global Asthma Preventive Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Asthma Preventive Revenue (2021-2032)
  8. 7.2.2 North America Asthma Preventive Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Asthma Preventive Revenue (2021-2032)
  11. 7.3.2 Europe Asthma Preventive Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Asthma Preventive Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Asthma Preventive Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Asthma Preventive Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Asthma Preventive Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Asthma Preventive Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Asthma Preventive Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Asthma Preventive Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Asthma Preventive Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GSK
  26. 8.5.1 GSK Company Information
  27. 8.5.2 GSK Business Overview
  28. 8.5.3 GSK Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GSK Asthma Preventive Product Portfolio
  30. 8.5.5 GSK Recent Developments
  31. 8.6 Amgen
  32. 8.6.1 Amgen Company Information
  33. 8.6.2 Amgen Business Overview
  34. 8.6.3 Amgen Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Amgen Asthma Preventive Product Portfolio
  36. 8.6.5 Amgen Recent Developments
  37. 8.7 Astrazeneca
  38. 8.7.1 Astrazeneca Company Information
  39. 8.7.2 Astrazeneca Business Overview
  40. 8.7.3 Astrazeneca Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Astrazeneca Asthma Preventive Product Portfolio
  42. 8.7.5 Astrazeneca Recent Developments
  43. 8.8 Sumitomo Dainippon Pharma
  44. 8.8.1 Sumitomo Dainippon Pharma Company Information
  45. 8.8.2 Sumitomo Dainippon Pharma Business Overview
  46. 8.8.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio
  48. 8.8.5 Sumitomo Dainippon Pharma Recent Developments
  49. 8.9 Chiesi
  50. 8.9.1 Chiesi Company Information
  51. 8.9.2 Chiesi Business Overview
  52. 8.9.3 Chiesi Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Chiesi Asthma Preventive Product Portfolio
  54. 8.9.5 Chiesi Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Asthma Preventive Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
  61. 8.11 Biotest AG
  62. 8.11.1 Biotest AG Company Information
  63. 8.11.2 Biotest AG Business Overview
  64. 8.11.3 Biotest AG Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biotest AG Asthma Preventive Product Portfolio
  66. 8.11.5 Biotest AG Recent Developments
  67. 8.12 Abbot
  68. 8.12.1 Abbot Company Information
  69. 8.12.2 Abbot Business Overview
  70. 8.12.3 Abbot Asthma Preventive Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Abbot Asthma Preventive Product Portfolio
  72. 8.12.5 Abbot Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Asthma Preventive Value Chain Analysis
  2. 9.1.1 Asthma Preventive Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Asthma Preventive Production Mode & Process
  6. 9.2 Asthma Preventive Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Asthma Preventive Distributors
  9. 9.2.3 Asthma Preventive Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst